Ozempic Injection, Solution
NDC Package 50090-5949-0

11-digit billing NDC: 50090594900 · Billing unit: ML · 3 ML per package

Package Information

Ozempic (semaglutide) injection is oZEMPIC is indicated:•as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.•to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.Limitations of Use•OZEMPIC has not been studied in patients with a history of pancreatitis. This formulation utilizes a injection, solution delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-5949 and is authorized under FDA application NDA209637.

Identification & Billing

NDC Package Code
50090-5949-0
Package Description
1 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC
Product Code
11-Digit Billing Format
50090594900
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
3 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ozempic
Non-Proprietary Name
Semaglutide
Substance Name
Semaglutide
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Usage Information
OZEMPIC is indicated:•as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.•to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.Limitations of Use•OZEMPIC has not been studied in patients with a history of pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis [see Warnings and Precautions (5.2)].•OZEMPIC is not indicated for use in patients with type 1 diabetes mellitus.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
Product Type
Human Prescription Drug
FDA Application #
NDA209637
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-30-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-5949-0 identifies a specific commercial package of 1 syringe, plastic in 1 carton / 3 ml in 1 syringe, plastic of Ozempic, a human prescription drug labeled by A-s Medication Solutions. This product is billed per "ML" milliliter and contains an estimated amount of 3 billable units per package. This injection, solution is formulated for subcutaneous use and contains semaglutide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on September 30, 2020. The current certification is valid through December 31, 2026.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090594900. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-5949-0
11-Digit CMS (5-4-2)
50090-5949-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.